SCHEMBL14979856

SCHEMBL14979856

CC1(C(N)C(=O)O)CCCCC1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC1A2 P43004 1/20 0.46
SLC1A1 P43005 1/20 0.46
DPP4 P27487 4/20 0.45
PITRM1 Q5JRX3 4/20 0.45
DPP8 Q6V1X1 4/20 0.45
DPP9 Q86TI2 4/20 0.45
DPP7 Q9UHL4 3/20 0.45
FAP Q12884 2/20 0.45
GRM1 Q13255 2/20 0.39
GRIK1 P39086 2/20 0.38
GRIK2 Q13002 1/20 0.38
ALDH1A1 P00352 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
SLC7A5 Q01650 1/20 0.37
TSHR P16473 1/20 0.35
NFKB1 P19838 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22746096 1.00 SLC1A2 (0.46) SLC1A2SLC1A1DPP4PITRM1DPP8
SCHEMBL8262232 1.00 SLC1A2 (0.46) SLC1A2SLC1A1DPP4PITRM1DPP8
SCHEMBL22746095 1.00 SLC1A2 (0.46) SLC1A2SLC1A1DPP4PITRM1DPP8
Hydrochloric Acid SCHEMBL4535083 0.98 SLC1A2 (0.44) SLC1A2SLC1A1DPP4PITRM1DPP8
Hydrochloric Acid SCHEMBL29069903 0.98 SLC1A2 (0.44) SLC1A2SLC1A1DPP4PITRM1DPP8
SCHEMBL1482506 0.98 SLC1A2 (0.47) SLC1A2SLC1A1DPP4PITRM1DPP8
SCHEMBL31374917 0.98 SLC1A2 (0.47) SLC1A2SLC1A1DPP4PITRM1DPP8
Hydrochloric Acid SCHEMBL28004131 0.95 SLC1A2 (0.46) SLC1A2SLC1A1DPP4PITRM1DPP8
Hydrochloric Acid SCHEMBL15412292 0.95 SLC1A2 (0.46) SLC1A2SLC1A1DPP4PITRM1DPP8
SCHEMBL23462330 0.93 SLC1A2 (0.47) SLC1A2SLC1A1DPP4PITRM1DPP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119306790-A Amide derivative, composition and use thereof 深圳市塔吉瑞生物医药有限公司 2025-01-14 CN disclosed
US-9328138-B2 HCV NS3 protease inhibitors MSD ITALIA S.R.L. (IT) 2016-05-03 US disclosed
US-9328138-B2 HCV NS3 protease inhibitors MSD ITALIA S.R.L. (IT) 2016-05-03 US disclosed
US-20140296136-A1 HCV NS3 PROTEASE INHIBITORS MERCK SHARP & DOHME LLC 2014-10-02 US disclosed
US-20140296136-A1 HCV NS3 PROTEASE INHIBITORS MERCK SHARP & DOHME LLC 2014-10-02 US disclosed
WO-2013074386-A2 HCV NS3 PROTEASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2013-05-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140296136-A1 HCV NS3 PROTEASE INHIBITORS HAVCR2, GTF3C3, CTSC SLC1A2 4616/4885SLC1A1 3846/4885DPP4 29/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.